WRF
AGN

Waddell & Reed Financial’s Allergan Inc AGN Stock Holding History

Waddell & Reed Financial’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,116,679
Closed -$237M – 619
2014
Q4 		$237M Sell
1,116,679
-993,973
-47% -$198M 0.33% 88
2014
Q3 		$376M Buy
2,110,652
+1,772,652
+524% +$294M 0.52% 61
2014
Q2 		$57.2M Buy
338,000
+188,000
+125% +$29.3M 0.08% 227
2014
Q1 		$18.6M Sell
150,000
-45,000
-23% -$5.48M 0.03% 347
2013
Q4 		$21.7M Sell
195,000
-8,410
-4% -$803K 0.03% 320
2013
Q3 		$18.4M Sell
203,410
-973,711
-83% -$87.4M 0.04% 325
2013
Q2 		$99.2M Buy
+1,177,121
New +$122M 0.21% 121

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Waddell & Reed Financial's AGN Position: Q1 2015 in Review

Waddell & Reed Financial sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 1,116,679 shares — an estimated $237M sold.

Waddell & Reed Financial first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $376M in Q3 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Waddell & Reed Financial reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Waddell & Reed Financial sold 1,116,679 Allergan Inc shares in Q1 2015, an estimated $237M.
  • Waddell & Reed Financial first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Waddell & Reed Financial's Allergan Inc position peaked at $376M in Q3 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Waddell & Reed Financial's 13F filing for Q1 2015, filed 15 May 2015.